Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Twist Bioscience Corp (NQ: TWST ) 43.55 +0.76 (+1.78%) Streaming Delayed Price Updated: 10:22 AM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Twist Bioscience Corp < Previous 1 2 ... 8 9 10 11 12 13 14 15 Next > Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors August 06, 2021 From Twist Bioscience Corporation Via Business Wire Earnings Scheduled For August 6, 2021 August 06, 2021 Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million.... Via Benzinga Earnings Scheduled For May 6, 2021 May 06, 2021 Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen... Via Benzinga The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs August 01, 2021 Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... Via Benzinga Exposures Product Safety Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery July 26, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests July 22, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021 July 21, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Acquires NGS Library Preparation Maker iGenomX June 30, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening June 14, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Announces Fireside Chat and Presentation at BIO Digital June 14, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Stock Hits 80-Plus Relative Strength Rating Benchmark June 11, 2021 TwistBioscienceCorp shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82. Via Investor's Business Daily DNA Data Storage Alliance Publishes First White Paper, Launches Website June 10, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests June 08, 2021 From Twist Bioscience Corporation Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For June 4, 2021 June 04, 2021 Upgrades According to Argus Research, the prior rating for Diageo PLC (NYSE:DEO) was changed from Hold to Buy. The current stock performance of Diageo shows a 52-week-high... Via Benzinga 2 Top Biotech Picks to Buy and Hold for the Next 10 Years May 29, 2021 Incredible scientific advances could reward investors -- if they have the patience. Via The Motley Fool Twist Bioscience Stock Scores Relative Strength Rating Upgrade May 28, 2021 When adding stocks to your watch list, look for stocks with an 80 or higher RS Rating. Twist Bioscience just met that criteria with a new score of 84. Via Investor's Business Daily Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications May 25, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Present at Upcoming Virtual Conferences May 25, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Supports the Engineering Biology Research Consortium as it Publishes Statement of Ethics May 13, 2021 From Twist Bioscience Corporation Via Business Wire 12 Health Care Stocks Moving In Monday's Intraday Session May 10, 2021 Gainers Protagenic Therapeutics (NASDAQ:PTIX) shares increased by 84.03% to $3.92 during Monday's regular session. Trading volume for this security as of 12:30 EST is... Via Benzinga 64 Biggest Movers From Yesterday May 11, 2021 Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3.... Via Benzinga Barron's Picks And Pans: Hannon Armstrong, Seagate, Tesla, Virtu Financial And More May 09, 2021 This weekend's Barron's cover story helps investors to prepare for the changes ahead. Other featured articles discuss how to invest in tomorrow's big tech trends,... Via Benzinga What Are the Risks With Twist Bioscience? May 08, 2021 One especially stands out. Via The Motley Fool Twist Bioscience Corp (TWST) Q2 2021 Earnings Call Transcript May 07, 2021 TWST earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results May 06, 2021 From Twist Bioscience Corporation Via Business Wire Why Does Cathie Wood Like This Healthcare Stock So Much? May 06, 2021 Twist Bioscience brings to mind another genomic revolution pioneer. Via The Motley Fool 3 Exciting Biotech Stocks to Buy Right Now April 30, 2021 Gene therapies could be poised to enter an era of extraordinarily rapid advancement. Via The Motley Fool The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom May 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications April 28, 2021 From Twist Bioscience Corporation Via Business Wire < Previous 1 2 ... 8 9 10 11 12 13 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.